OREXIGEN THERAPEUTICS INC's ticker is OREXQ and the CUSIP is 686164302. A total of 51 filers reported holding OREXIGEN THERAPEUTICS INC in Q2 2017. The put-call ratio across all filers is 1.84 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2018 | $108,000 | -88.6% | 534,900 | -27.2% | 0.01% | -90.4% |
| Q4 2017 | $948,000 | -39.2% | 734,976 | 0.0% | 0.11% | -42.4% |
| Q3 2017 | $1,558,000 | -26.9% | 734,976 | 0.0% | 0.20% | -40.2% |
| Q2 2017 | $2,131,000 | -15.7% | 734,976 | 0.0% | 0.33% | -23.0% |
| Q1 2017 | $2,528,000 | +97.7% | 734,976 | 0.0% | 0.43% | +67.3% |
| Q4 2016 | $1,279,000 | -47.6% | 734,976 | 0.0% | 0.26% | -44.1% |
| Q3 2016 | $2,440,000 | – | 734,976 | – | 0.46% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|